Eton Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ETON Eton Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
BVS Bioventus Inc
TDS-U Telephone and Data Systems Inc
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.

Day's Change
-0.02 (-0.51%)
B/A Size
Day's High
Day's Low

Today's volume of 4,137 shares is on pace to be much lighter than ETON's 10-day average volume of 46,800 shares.


NSC SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Norfolk Southern (NSC) Investors with Substantial Losses to Contact Firm's Attorneys, Securities Class Action Filed

4:30 pm ET March 22, 2023 (Accesswire) Print

SAN FRANCISCO, CA / ACCESSWIRE / March 22, 2023 /Hagens Berman urges Norfolk Southern Corporation (NYSE:NSC) investors who suffered substantial losses to submit your losses now.

Class Period: Oct. 8, 2020 - Mar. 3, 2023

Lead Plaintiff Deadline: May 15, 2023

Contact An Attorney


Norfolk Southern Corporation (NSC) Securities Fraud Class Action:

The complaint alleges that Defendants misrepresented and concealed material facts concerning Norfolk Southern's increased risk-taking at the expense of reasonable safety precautions due to the company's near-term focus on profits.

Specifically, the company invoked a plan to, among other things, use longer, heavier trains staffed by fewer personnel, which led to increased train derailments and the risk of future catastrophic events. The complaint also alleges that while failing to make proper capital expenditures in safety risk programs, the company concurrently lobbied for policies undermining its ability to provide safe, efficient, and reliable rail transportation services.

The complaint alleges that this undisclosed conduct made Norfolk Southern more susceptible to accidents that could seriously harm the company, its workers, its customers, third parties, and the environment.

The true facts began to emerge on Feb. 3, 2023, when a Norfolk Southern freight train derailed in East Palestine, Ohio. The derailed equipment included 11 tank cars carrying hazardous materials that subsequently ignited and required the immediate evacuation of those within a one-mile by two-mile area. According to regulators, the derailment was entirely preventable.

An additional revelation of Norfolk Southern's safety lapses occurred on Mar. 14, 2023, when another of its freight trains derailed near Springfield, Ohio.

"We're focused on investors' losses and proving Norfolk Southern put profits over safety," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Norfolk Southern and have substantial losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Norfolk Southern should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email

# # #

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at Follow the firm for updates and news at @ClassActionLaw.


Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

View source version on

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.